MeSH Browser

MeSH Heading: Aminosalicylic Acid
Tree Number(s): D02.241.223.100.050.500.642; D02.241.223.100.300.595.100.060; D02.241.511.390.595.100.060; D02.455.426.559.389.127.020.937.642; D02.455.426.559.389.127.281.595.100.060; D02.455.426.559.389.657.410.595.100.060
Unique ID: D010131
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D010131
Annotation: AMINOSALICYLIC ACIDS is also available
Scope Note: An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.
Entry Term(s): 4-Aminosalicylic Acid; Alumino-4-Aminosalicylic Acid; Pamisyl; Rezipas; p-Aminosalicylic Acid; p-Aminosalicylic Acid Monolithium Salt; p-Aminosalicylic Acid Monopotassium Salt; p-Aminosalicylic Acid Monosodium Salt; p-Aminosalicylic Acid, Aluminum (2:1) Salt; p-Aminosalicylic Acid, Calcium (2:1) Salt; p-Aminosalicylic Acid, Monosodium Salt, Dihydrate; para-Aminosalicylic Acid
Pharm Action: Antitubercular Agents
Registry Number: 5B2658E0N2
Related Numbers: 133-09-5; 133-10-8; 133-15-3; 6018-19-5; 61891-33-6; 64240-79-5; 65-49-6; S38B9W6AXW
CAS Type 1 Name: Benzoic acid, 4-amino-2-hydroxy-
Previous Indexing: Aminosalicylic Acids (1966-1976)
Public MeSH Note: 2010,1963-1976. see p-Aminocalicylic acid. 1977-2009, see AMINOSALICYLIC ACIDS 1977-90; for PAS see AMINOSALICYCLIC ACID 1963-1967
History Note: 2010, 1963-1976
Entry Combination: analogs & derivatives:Aminosalicylic Acids
Date Established: 1991/01/01
Date of Entry: 1976/05/19
Revision Date: 2013/07/08

Entry Combination: analogs & derivatives:Aminosalicylic Acids
Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Organic Chemicals [D02]
- Carboxylic Acids [D02.241]
  - Acids, Carbocyclic [D02.241.223]
    - Benzoates [D02.241.223.100]
      - Aminobenzoates [D02.241.223.100.050]
        
        para-Aminobenzoates [D02.241.223.100.050.500]
        
        Acecainide [D02.241.223.100.050.500.625]
        
        4-Aminobenzoic Acid [D02.241.223.100.050.500.640]
        
        Aminosalicylic Acid [D02.241.223.100.050.500.642]
        
        Benzocaine [D02.241.223.100.050.500.643]
        
        Cisapride [D02.241.223.100.050.500.644]
        
        Ethopabate [D02.241.223.100.050.500.645]
        
        Metoclopramide [D02.241.223.100.050.500.647]
        
        p-Aminohippuric Acid [D02.241.223.100.050.500.650]
        
        Procainamide [D02.241.223.100.050.500.875]
        
        Procaine [D02.241.223.100.050.500.906]
        
        Propoxycaine [D02.241.223.100.050.500.937]
        
        Tetracaine [D02.241.223.100.050.500.968]

Organic Chemicals [D02]
- Carboxylic Acids [D02.241]
  - Acids, Carbocyclic [D02.241.223]
    - Benzoates [D02.241.223.100]
      - Hydroxybenzoates [D02.241.223.100.300]
        
        Salicylates [D02.241.223.100.300.595]
        
        Aminosalicylic Acids [D02.241.223.100.300.595.100]
        
        Aminosalicylic Acid [D02.241.223.100.300.595.100.060]
        
        Mesalamine [D02.241.223.100.300.595.100.540]

Organic Chemicals [D02]
- Carboxylic Acids [D02.241]
  - Hydroxy Acids [D02.241.511]
    - Hydroxybenzoates [D02.241.511.390]
      - Salicylates [D02.241.511.390.595]
        
        Aminosalicylic Acids [D02.241.511.390.595.100]
        
        Aminosalicylic Acid [D02.241.511.390.595.100.060]
        
        Mesalamine [D02.241.511.390.595.100.540]

Organic Chemicals [D02]
- Hydrocarbons [D02.455]
  - Hydrocarbons, Cyclic [D02.455.426]
    - Hydrocarbons, Aromatic [D02.455.426.559]
      - Benzene Derivatives [D02.455.426.559.389]
        
        Benzoates [D02.455.426.559.389.127]
        
        Aminobenzoates [D02.455.426.559.389.127.020]
        
        para-Aminobenzoates [D02.455.426.559.389.127.020.937]
        
        Acecainide [D02.455.426.559.389.127.020.937.625]
        
        4-Aminobenzoic Acid [D02.455.426.559.389.127.020.937.640]
        
        Aminosalicylic Acid [D02.455.426.559.389.127.020.937.642]
        
        Ethopabate [D02.455.426.559.389.127.020.937.645]
        
        Metoclopramide [D02.455.426.559.389.127.020.937.647]
        
        p-Aminohippuric Acid [D02.455.426.559.389.127.020.937.650]
        
        Benzocaine [D02.455.426.559.389.127.020.937.687]
        
        Cisapride [D02.455.426.559.389.127.020.937.700]
        
        Procainamide [D02.455.426.559.389.127.020.937.875]
        
        Procaine [D02.455.426.559.389.127.020.937.906]
        
        Propoxycaine [D02.455.426.559.389.127.020.937.937]
        
        Tetracaine [D02.455.426.559.389.127.020.937.968]

Organic Chemicals [D02]
- Hydrocarbons [D02.455]
  - Hydrocarbons, Cyclic [D02.455.426]
    - Hydrocarbons, Aromatic [D02.455.426.559]
      - Benzene Derivatives [D02.455.426.559.389]
        
        Benzoates [D02.455.426.559.389.127]
        
        Hydroxybenzoates [D02.455.426.559.389.127.281]
        
        Salicylates [D02.455.426.559.389.127.281.595]
        
        Aminosalicylic Acids [D02.455.426.559.389.127.281.595.100]
        
        Aminosalicylic Acid [D02.455.426.559.389.127.281.595.100.060]
        
        Mesalamine [D02.455.426.559.389.127.281.595.100.540]

Organic Chemicals [D02]
- Hydrocarbons [D02.455]
  - Hydrocarbons, Cyclic [D02.455.426]
    - Hydrocarbons, Aromatic [D02.455.426.559]
      - Benzene Derivatives [D02.455.426.559.389]
        
        Phenols [D02.455.426.559.389.657]
        
        Hydroxybenzoates [D02.455.426.559.389.657.410]
        
        Salicylates [D02.455.426.559.389.657.410.595]
        
        Aminosalicylic Acids [D02.455.426.559.389.657.410.595.100]
        
        Aminosalicylic Acid [D02.455.426.559.389.657.410.595.100.060]
        
        Mesalamine [D02.455.426.559.389.657.410.595.100.540]

Aminosalicylic Acid Preferred

Concept UI: M0000970
Registry Number: 5B2658E0N2
Related Numbers: 133-09-5; 133-10-8; 133-15-3; 6018-19-5; 61891-33-6; 64240-79-5; 65-49-6; S38B9W6AXW
Scope Note: An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.
Terms: Aminosalicylic Acid Preferred Term
Term UI T001910
Date05/22/1976
LexicalTag NON
ThesaurusID; 4-Aminosalicylic Acid
Term UI T029986
Date05/18/1976
LexicalTag NON
ThesaurusID; para-Aminosalicylic Acid
Term UI T029991
Date05/18/1976
LexicalTag NON
ThesaurusID; p-Aminosalicylic Acid
Term UI T029987
Date01/01/1999
LexicalTag ABX
ThesaurusID

p-Aminosalicylic Acid Monolithium Salt Narrower

p-Aminosalicylic Acid Monopotassium Salt Narrower

Rezipas Narrower

p-Aminosalicylic Acid, Aluminum (2:1) Salt Narrower

p-Aminosalicylic Acid, Calcium (2:1) Salt Narrower

p-Aminosalicylic Acid, Monosodium Salt, Dihydrate Narrower

Pamisyl Narrower

Alumino-4-Aminosalicylic Acid Narrower

p-Aminosalicylic Acid Monosodium Salt Narrower

Aminosalicylic Acid MeSH Descriptor Data 2023